Aldeyra Therapeutics, Inc.

ALDX ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
ARS May 24, 2023 ARS
DEF 14A May 23, 2023 DEF 14A
10-Q May 4, 2023 10-Q
8-K May 4, 2023 ALDEYRA THERAPEUTICS, INC. 8-K
10-K/A Apr 28, 2023 10-K/A
8-K Mar 10, 2023 8-K
S-8 Mar 9, 2023 S-8
10-K Mar 9, 2023 10-K
8-K Mar 9, 2023 ALDEYRA THERAPEUTICS, INC. 8-K
4 Mar 2, 2023 FORM 4 SUBMISSION
4 Mar 2, 2023 FORM 4 SUBMISSION
4 Mar 2, 2023 FORM 4 SUBMISSION
8-K Mar 2, 2023 ALDEYRA THERAPEUTICS, INC. 8-K
SC 13G/A Feb 14, 2023 SC 13G/A
8-K Feb 7, 2023 ALDEYRA THERAPEUTICS, INC. 8-K
SC 13G/A Feb 3, 2023
8-K Dec 27, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
8-K Dec 21, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
8-K Dec 1, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
8-K Nov 29, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
10-Q Nov 10, 2022 10-Q
8-K Nov 10, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
8-K Oct 6, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
8-K Sep 14, 2022 ALDEYRA THERAPEUTICS, INC. 8-K
4 Aug 11, 2022 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
← Newer Page 7 of 26 · 646 filings Older →